Society for Endocrinology - a world-leading authority on hormones

Clinical practice

Society position statements

Responses to important advances or changes in treatments, or topical issues in the field of endocrinology.

October 2010

Catecholamine-secreting phaeochromocytoma and paraganglioma
Protocol using oral phenoxybenzamine to prepare patients with catecholamine-secreting phaeochromocytoma and paraganglioma for surgery

Suggestion of an alternative whilst supplies of the intravenous compound are being restored (reviewed March 2012).

November 2011

Dopamine Agonists
Society for Endocrinology position statement on the use of dopamine agonists in endocrine disorders

This statement (originally issued in February 2009 and reviewed November 2011) was issued in response to information contained in the MHRA Drug Safety Update (Volume 2, Issue 3 October 2008).

October 2012

Hypogonadism
Society for Endocrinology position statement on hypogonadism and ageing

The Society for Endocrinology’s Clinical Committee provides information on the diagnosis and treatment of hypogonadism in ageing men. A patient factsheet to accompany this position statement can be found on the Society’s public-facing website You & Your Hormones.

September 2011
Under review

Hypothyroidism
The diagnosis and management of hypothyroidism. (The statement is available on the RCP website)

These guidelines, originally issued in November 2008, reviewed September 2011and formally re-endorsed by the Society for Endocrinology and the other co-publishing organisations.

July 2011

Inhaled Steroids
Endocrine effects of inhaled steroids in respiratory disease

This position statement highlights the suppressive effects of inhaled corticosteroids on the endogenous hypothalamo-pituitary-adrenal axis.

September 2011

Synacthen
Use of synthetic ACTH (Synacthen) in patients with a history of asthma

This statement is issued to coincide with the publication of BNF62 that contains (in section 6.5.1) an amendment to cautions and contraindications in the use of Tetracosactide (Tetracosactrin).

October 2011

Specialist Endocrinology Services
Society for Endocrinology’s information on specialist endocrinology services

This document (originally issued in July 2009 and recently reviewed) explains how the wide range of endocrine conditions are best diagnosed and managed by teams of doctors working in a variety of different clinical settings.

November 2014

Use of animals in medical research

The Society's position on the use of animals in medical research (original March 2010, reviewed April 2012, November 2014).